Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV
Keywords: انتخاب آنزیم; Protease inhibition; Dipeptidyl peptidase IV; Structure-based drug design; Enzyme selectivity; Pharmacokinetics; Ex vivo plasma DPP IV inhibition;